Aminoglutethimide for the treatment of advanced postmenopausal breast cancer
- 1 January 1983
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 19 (1), 11-17
- https://doi.org/10.1016/0277-5379(83)90390-5
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*Journal of Clinical Endocrinology & Metabolism, 1978
- Tamoxifen in advanced breast cancerCancer Treatment Reviews, 1978
- AMINOGLUTETHIMIDE IN TREATMENT OF METASTATIC BREAST CARCINOMAThe Lancet, 1978
- Tamoxifen (Antiestrogen) Therapy in Advanced Breast CancerAnnals of Internal Medicine, 1977
- Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancerCancer, 1977
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Assessment of response to therapy in advanced breast cancerEuropean Journal of Cancer (1965), 1977
- Bilateral Adrenalectomy for Metastatic Breast CarcinomaArchives of Surgery, 1975
- Source of Estrogen Production in Postmenopausal Women1Journal of Clinical Endocrinology & Metabolism, 1973
- Aminoglutethimide (Elipten-Ciba) as an Inhibitor of Adrenal Steroidogenesis: Mechanism of Action and Therapeutic TrialJournal of Clinical Endocrinology & Metabolism, 1967